Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
暂无分享,去创建一个
Stephen R. Williams | V. D. Der Kaloustian | H. Toriello | R. Magenis | G. Gowans | S. Elsea | M. Aldred | F. Halal | D. R. Mcleod | Sara Zondag | V. Kaloustian
[1] S. Mundlos,et al. Deletion and point mutations of PTHLH cause brachydactyly type E. , 2010, American journal of human genetics.
[2] Deborah L. Levy,et al. A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.
[3] M. Chiong,et al. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. , 2009, Biochemical and biophysical research communications.
[4] Stephen R. Williams,et al. Array comparative genomic hybridisation of 52 subjects with a Smith–Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay , 2009, Journal of Medical Genetics.
[5] Axel Benner,et al. FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome , 2009, American journal of medical genetics. Part A.
[6] Santhosh Girirajan,et al. A functional network module for Smith–Magenis syndrome , 2009, Clinical genetics.
[7] Constance L. Cepko,et al. HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas , 2009, Science.
[8] K. Casas,et al. Chromosome 2q37 deletion: Clinical and molecular aspects , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.
[9] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[10] John McAnally,et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. , 2007, Developmental cell.
[11] G. Karsenty,et al. PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. , 2006, Developmental biology.
[12] M. Humbert,et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.
[13] J. Piven,et al. Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[14] K. Devriendt,et al. RAI1 variations in Smith–Magenis syndrome patients without 17p11.2 deletions , 2005, Journal of Medical Genetics.
[15] K. Reddy. Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder , 2005, BMC Medical Genetics.
[16] A E Shrimpton,et al. Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy‐like phenotype , 2004, Clinical genetics.
[17] John M. Shelton,et al. Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis , 2004, Cell.
[18] R. Hennekam,et al. Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes , 2004, Journal of Medical Genetics.
[19] Chun Li Zhang,et al. Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.
[20] M. Spence,et al. Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR , 2001, Cytogenetic and Genome Research.
[21] N. Kanatani,et al. Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.
[22] S. Takeda,et al. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.
[23] S. Schreiber,et al. Three proteins define a class of human histone deacetylases related to yeast Hda1p. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] W. Dobyns,et al. Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. , 1995, American journal of medical genetics.
[25] J. Flint,et al. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. , 1995, American journal of human genetics.
[26] F. Dequiedt,et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.
[27] E. Olson,et al. MEF2: a calcium-dependent regulator of cell division, differentiation and death. , 2002, Trends in biochemical sciences.
[28] J. Charles,et al. Pilot assessment of the subtelomeric regions of children with autism: Detection of a 2q deletion , 2002, Genetics in Medicine.
[29] B. Black,et al. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.